Andy Barnett
Head of Investor Relations
Replay available
AstraZeneca PLC (AZN) Q2 2025 Earnings Call
AstraZeneca PLC (NASDAQ: AZN) Q2 2025 earnings conference call, held 2025-07-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Pascal Soriot
Chief Executive Officer
Aradhana Yerramilli
Chief Financial Officer
Dave Fredrickson
Executive Vice President, Oncology Business Unit
Susan Galbraith
Executive Vice President, Oncology R&D
Ruud Dobber
Executive Vice President, Biopharmaceuticals
Sharon Fetter
Executive Vice President, Cardiovascular, Renal & Metabolism
Marc Dunoyer
Executive Vice President, Rare Disease
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.638 Good afternoon and welcome to AstraZeneca's H1 and Q2 2025 webinar 00:00:05.638 -- 00:00:08.402 for investors and analysts. 00:00:08.402 -- 00:00:13.666 Before I hand over to AstraZeneca, I'd like to read the Safe Harbor Statement. 00:00:13.989 -- 00:00:18.095 The company intends to utilize the Safe Harbor provisions of the United States Private 00:00:18.095 -- 00:00:22.338 Securities Litigation Reform Act of 1995. 00:00:22.481 -- 00:00:26.966 Participants on this call may make forward-looking statements with respect to the operations 00:00:26.966 -- 00:00:30.136 and financial performance of AstraZeneca. 00:00:30.136 -- 00:00:34.543 Although we believe our expectations are based on reasonable assumptions, by their very 00:00:34.543 -- 00:00:39.671 nature, forward-looking statements involve risks and uncertainties, and may be influenced 00:00:39.671 -- 00:00:44.618 by factors that could cause actual results to differ materially from those expressed 00:00:44.618 -- 00:00:48.244 or implied by these forward-looking statements. 00:00:48.244 -- 00:00:52.050 Any forward-looking statements made on this call reflect the knowledge and information 00:00:52.050 -- 00:00:55.275 available at the time of this call. 00:00:55.275 -- 00:01:00.005 The company undertakes no obligation to update forward-looking statements. 00:01:00.005 -- 00:01:04.091 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:04.091 -- 00:01:07.676 that accompanies this presentation and webcast. 00:01:07.676 -- 00:01:11.922 There will be an opportunity to ask questions after today's presentations. 00:01:11.922 -- 00:01:16.269 Please use the raise a hand feature to indicate you wish to ask a question at any time 00:01:16.269 -- 00:01:...